Durolane
Sponsors
Bioventus LLC, Assistance Publique Hopitaux De Marseille, Galderma R&D, OPKO Health, Inc., SciVision Biotech Inc.
Conditions
Knee OsteoarthritisOsteoarthritisOsteoarthritis, Kneethe Treatment of Knee Osteoarthritis
Phase 2
Unknown Phase
Comparative Study of Safety and Efficacy of Two Hyaluronic Acids for the Treatment of Knee Osteoarthritis Pain
CompletedNCT01295580
Start: 2011-01-31End: 2012-02-29Updated: 2021-04-09
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
TerminatedNCT01753830
Start: 2012-12-31End: 2014-02-28Updated: 2022-08-26
Prospective Single Center Open Label Study of Shoulder OA Pain
CompletedNCT02610504
Start: 2015-04-08End: 2017-05-23Updated: 2021-02-16
Efficacy and Safety of a Intra-articular Injection, ENKO1, in Patients With Symptomatic Knee Osteoarthritis.
CompletedNCT03762408
Start: 2017-12-15End: 2020-05-29Updated: 2021-03-23
The Comparison of Two Crosslinked Hyaluronate for the Treatment of Osteoarthritis Pain
CompletedNCT04000204
Start: 2017-06-20End: 2019-07-12Updated: 2020-05-27